Incidence of thromboembolic events in patients with locally advanced rectal cancer receiving neoadjuvant chemoradiotherapy

1Department of Radiology, Oncology and Human Pathology, Division of Oncology B, “Sapienza” University of Rome, Rome, Italy, 2Department of Radiology, Oncology and Human Pathology, Division of Radiotherapy “Sapienza” University of Rome, Rome, Italy, 3Department of Surgical Science, Division of DEA, “Sapienza” University of Rome, Rome, Italy, 4Carnegie Mellon University, Pittsburg, USA, and 5Department of Statistical Science, “Sapienza” University of Rome, Rome, Italy

[1]  T. Hothorn,et al.  O-0028PREOPERATIVE CHEMORADIOTHERAPY AND POSTOPERATIVE CHEMOTHERAPY WITH 5-FLUOROURACIL AND OXALIPLATIN VERSUS 5-FLUOROURACIL ALONE IN LOCALLY ADVANCED RECTAL CANCER: RESULTS OF THE GERMAN CAO/ARO/AIO-04 RANDOMIZED PHASE III TRIAL , 2014 .

[2]  L. Boni,et al.  Primary tumor response to preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer: pathologic results of the STAR-01 randomized phase III trial. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  T. Hothorn,et al.  Preoperative chemoradiotherapy and postoperative chemotherapy with 5-fluorouracil and oxaliplatin versus 5-fluorouracil alone in locally advanced rectal cancer: First results of the German CAO/ARO/AIO-04 randomized phase III trial. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  N. Petrelli,et al.  The impact of capecitabine and oxaliplatin in the preoperative multimodality treatment in patients with carcinoma of the rectum: NSABP R-04. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  H. Abdel-Razeq,et al.  Incidental pulmonary embolism in cancer patients: clinical characteristics and outcome – a comprehensive cancer center experience , 2011, Vascular health and risk management.

[6]  T. Hothorn,et al.  Preoperative chemoradiotherapy and postoperative chemotherapy with 5-fluorouracil and oxaliplatin versus 5-fluorouracil alone in locally advanced rectal cancer: First results of the German CAO/ARO/AIO-04 randomized phase III trial. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  A. Khorana,et al.  Emerging risk stratification approaches to cancer-associated thrombosis: risk factors, biomarkers and a risk score. , 2010, Thrombosis research.

[8]  Christophe Hennequin,et al.  Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: results of the phase III trial ACCORD 12/0405-Prodige 2. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  A. Norman,et al.  Thromboembolism in patients with advanced gastroesophageal cancer treated with anthracycline, platinum, and fluoropyrimidine combination chemotherapy: a report from the UK National Cancer Research Institute Upper Gastrointestinal Clinical Studies Group. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  Gary H Lyman,et al.  Development and validation of a predictive model for chemotherapy-associated thrombosis. , 2008, Blood.

[11]  Lars Påhlman,et al.  Late adverse effects of radiation therapy for rectal cancer – a systematic overview , 2007, Acta oncologica.

[12]  Daniel Azoulay,et al.  Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  H. Chew,et al.  Venous thromboembolism in patients with colorectal cancer: incidence and effect on survival. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  A. Norman,et al.  Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  Tufia C Haddad,et al.  Chemotherapy-induced thrombosis. , 2006, Thrombosis research.

[16]  J. Heit Cancer and venous thromboembolism: scope of the problem. , 2005, Cancer control : journal of the Moffitt Cancer Center.